Newsroom | 7930 results

Sorted by: Latest

Cardiology
-

HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics to Present on RNA-guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)...
-

Butterfly Network Reports First Quarter 2025 Financial Results

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “2025 is off to a great start. The Butterfly team hit the mark...
-

Savara Announces Participation in the Upcoming Citizens Life Sciences Conference 

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will be hosting 1x1 meetings and participating in a fireside chat at the Citizens Life Sciences Conference on Thursday, May 8, 2025 at 10:30am EST/7:30am PST. The live webcast and subsequent replay will be available on the “Events & Presentations” section of the Company’s corporate webs...
-

Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator

SAN FRANCISCO--(BUSINESS WIRE)--Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator...
-

Dream Performance & Recovery Launches Second Wind Nasal Strips

BOSTON--(BUSINESS WIRE)--Dream Performance & Recovery, a leading innovator in the sleep performance industry, today announced the launch of Second Wind Nasal Strips. Known for its best-selling Dream Tape, the brand is now unlocking peak performance with the future of nasal breathing. The benefits of nasal breathing have been widely researched to improve cardiovascular health, enhance endurance, increase alertness, and even aid in sleep apnea struggles. Now, with Second Wind Nasal Strips, us...
-

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time...
-

The Vascular Care Group Partners with the Massachusetts Department of Public Health to Provide Access to High-Quality Vascular Care at Lemuel Shattuck Hospital

BOSTON--(BUSINESS WIRE)--The Vascular Care Group (TVCG), the largest independent group of board-certified vascular specialists in the United States, is proud to announce a new partnership with Lemuel Shattuck Hospital, located in the Jamaica Plain neighborhood of Boston. This collaboration aims to meet a critical need for vascular care services at the state-owned, Department of Public Health–run facility. Lemuel Shattuck Hospital is recognized for delivering acute, subacute, and ambulatory care...
-

F45 Training Partners With Dietitian Live to Fuel Performance Through Personalized Nutrition

AUSTIN, Texas--(BUSINESS WIRE)--F45 Training, a global fitness community specializing in high-intensity, team-based functional training, today announced an exciting partnership with Dietitian Live, a leading telehealth company providing personalized dietitian services. This collaboration expands access to insurance-covered, science-backed nutrition coaching for F45 Training members nationwide. Following a successful pilot across 100 F45 Training studios that matched over 1,000 members with regi...
-

Organon Reports Results for the First Quarter Ended March 31, 2025

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon reports earnings results for Q1 2025, ended March 31, 2025....
-

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA technology will be featured in a presentation and a preclinical poster featuring the nsPFA Cardiac Surgical System at the American Association for Thoracic Surgery (AATS) 2025 Annual Meeting, being held May 2-5 in Seattle, Washington. “We believe the Nanosecond PFA...